Loading...
•
Jun 30, 2021
Teladoc Q2 2021 Earnings Report
Teladoc Health's second quarter results for 2021 showed significant revenue growth and strategic advancements.
Key Takeaways
Teladoc Health reported a strong second quarter with revenue growing 109% year-over-year to $503 million. The company also raised its full-year revenue guidance to $2.000 million to $2.025 million. Total visits increased by 28% compared to the same quarter last year, reaching 3.5 million.
Revenue increased by 109% year-over-year, reaching $503 million.
Full-year revenue guidance was raised to $2.000 million to $2.025 million.
Total visits for the quarter topped 3.5 million, a 28% increase year-over-year.
A significant new agreement was established with HCSC to provide chronic care solutions.
Revenue by Geographic Location
Forward Guidance
Teladoc Health provides revenue guidance for Q3 2021 to be in the range of $510 million to $520 million. The company expects total visits to be between 3.4 million and 3.6 million. For the full year 2021, Teladoc Health expects revenue in the range of $2,000 million to $2,025 million and total visits between 13.5 million and 14.0 million.
Positive Outlook
- Total revenue to be in the range of $510 million to $520 million for Q3 2021.
- Adjusted EBITDA to be in the range of $60 million to $65 million for Q3 2021.
- Total U.S. paid membership to be in the range of 52 million to 53 million members for Q3 2021.
- Total visits to be between 3.4 million and 3.6 million for Q3 2021.
- Total revenue to be in the range of $2,000 million to $2,025 million for full year 2021.
Challenges Ahead
- EBITDA to be in the range of $(31) million to $(26) million for Q3 2021.
- Net loss per share to be between $(0.78) and $(0.68) for Q3 2021.
- EBITDA to be in the range of $(120) million to $(100) million for full year 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...